These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6101934)

  • 61. Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
    McLenachan JM; Wilson JT; Dargie HJ
    Br Heart J; 1988 Jun; 59(6):685-9. PubMed ID: 2899439
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of metoprolol in angina pectoris. A subacute study with exercise tests and a long-term tolerability study.
    Keyriläinen O; Uusitalo A
    Acta Med Scand; 1976; 199(6):491-7. PubMed ID: 7100
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of cedilanid-D in combination with metoprolol on exercise tolerance and systolic time intervals in angina pectoris.
    Ekelund LG; Johnsson G; Melcher A; Oro L
    Am J Cardiol; 1976 Mar; 37(4):630-4. PubMed ID: 3961
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Felodipine in chronic stable angina: a randomized, double-blind, placebo-controlled, crossover study.
    Sangiorgio P; Di Pasquale G; Savonitto S; Urbinati S; Rubboli A; Cavallotti G; Pinelli G; Bracchetti D
    Eur Heart J; 1990 Nov; 11(11):1011-7. PubMed ID: 2282920
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test. A double-blind, randomized subacute study.
    Ekelund LG; Orö L
    Clin Cardiol; 1979 Jun; 2(3):203-11. PubMed ID: 389513
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Pharmacodynamics of the new beta blockader corgard (nadolol) in patients with stress-induced angina pectoris].
    Nikolenko SA; Metelitsa VI; Nazarenko VA; Martsevich SIu; Kulikova TV
    Kardiologiia; 1984 Feb; 24(2):14-8. PubMed ID: 6143849
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris.
    Vandenbosch H; Piessens J; De Geest H
    Acta Cardiol; 1991; 46(1):11-25. PubMed ID: 1674394
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise.
    Higginbotham MB; Morris KG; Coleman RE; Cobb FR
    Am J Cardiol; 1986 May; 57(13):1022-8. PubMed ID: 3085464
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of a new vasodilating beta-blocking agent, carvedilol, in exertional angina using holter monitoring.
    Kishida H; Saito T; Fukuma N; Hata N; Suzuki T; Ohtsu F
    Jpn Heart J; 1990 Jul; 31(4):449-60. PubMed ID: 1977939
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
    Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sotalol in angina pectoris. A double-blind study.
    Slome R
    S Afr Med J; 1976 Mar; 50(12):469-72. PubMed ID: 818720
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectoris.
    Lahiri A; Rodrigues EA; Al-Khawaja I; Raftery EB
    Am J Cardiol; 1987 Apr; 59(8):769-74. PubMed ID: 2881480
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of penbutolol (Hoe 893 d) and practolol on exercise-induced angina pectoris 2 and 24 hours after a signle oral dose.
    Westheim AS; Christensen CC; Kjekshus J
    Eur J Clin Pharmacol; 1978 May; 13(3):157-62. PubMed ID: 27370
    [No Abstract]   [Full Text] [Related]  

  • 75. Verapamil therapy for stable exertional angina pectoris.
    Weiner DA; Klein MD
    Am J Cardiol; 1982 Nov; 50(5):1153-7. PubMed ID: 6814225
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.
    Wilson AG; Brooke OG; Lloyd HJ; Robinson BF
    Br Med J; 1969 Nov; 4(5680):399-401. PubMed ID: 4390958
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: a double-blind study.
    Araki H; Hayata N; Nakamura M
    Clin Ther; 1987; 9(6):656-62. PubMed ID: 2894246
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Angina pectoris: effective therapy once daily.
    Prager G
    J Int Med Res; 1979; 7(1):39-44. PubMed ID: 33863
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U; Ezekowitz M; Fenney L; Chiang YK
    Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.